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    The absorption of 3H－adriamycin through rat’ urinary bladder and the subsequent distribution
and excretion of the absorbed adriamycin were studied．
    Male MTistar rats weighing 30e to 3j”O g were used． A ureter was exposed and half－incised trans－
versely， using a stereoscopic microscope． A pelyethylene tube with an outer diameter ol’ O．024 jnches
was inserted through this incision， in the same rrianner as an ureterostomy， and the ’opposite kidney
was extirpated． As t”or the bile， the same tube was inserted into the biie duct． Then， 3H－adriamycin
（10．79 pCi／O．3 ml／300 ptg adriamycin） was injected into the bladder． Following the instillation Qf
the adriamycin over an one hour period， the filled．bladder was excised． Therea’fter the urine and
bile werg cf．11g，gtgq． evely．．3 hg， urs fgr． the．．next．1．2 hours． ． ln another groyp， the livgr， spleen， kidncy
and heart were extirpated ・1 ・and 12 hours after the injection， respectively．
   The followring results were 6btained．
    1） The recovery rate of the residual 3H－adriamycin in bladder one hour after instillation was
81．70／． and the vesical tissue level was 175．9 ptg／g on an average．
   2） The tissue concentrations of 3H－adriamycin one hour aftet the injection were O．19 ptg／g in
the liver， O．36 ptgfg in the spleen， O．31 ptg／g in the kidney， and O．21 ptgfg in the heart．
   3） The recovery rate of 3｝1－adriamycin into ．the urine was O．660／，， and the rate of it into bile was
4．220／， during 12 hours．
   4） The tissue concentratiens of 3H－adriarnycin 12 hours after the injection were O．52 yg／g in
the liver， O．67 ptg／g in the spleen， O．49 ptgfg in the 1〈idney and O．9J3 geg／g in the heart．
   Adriamycin is well absorbed through bladder， and then distributed to various orgaps， particularly
















































Table 1．Recovery rate of the residual 3H－
adriamycin in rat bladder and its
vesical tissue levei after 1 hour of
instillation．





































o 3 6 9 12 hrs，
          Time after instiUation
Fig． 1． Biliary and urinary recovery of the
    instilled 3H－adriamycin in urinary－
    diverted rats．
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Table 2． Biliary and urinary excretion of the instilled 3H－adriamycin．
bile
丁ime after instillation              con－          volume ’1ddntration
urine
recovery volumecon－centrationrecovery
〇一3h 0，4ml 2、08四1ml O．83四〇．28％ 2．Om［ 3．55 pglml 7ユ〇四2．37％
3－6 e．s O．83 O．42 O．Z4 1．5王．76 2．64 O．88
6－9 O．5 o．ua e．22 O．07 1．1Z．54 1．69 O．56
9一 12 L3 O．39 O．Sl O．17 O．71．74 1．22 O．41
Table 3． Tissue levels of 3H－adriamycin after
     the instillatien，





































































































































































．永田：経膀胱的吸収．・．耳3．・adria即ycin．．   ’        895
つた．      ．
 4）ad・iamycin．は組織との親和性が強く，その排．
泄は非常に緩徐であるため；一且，吸収される．と長時
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